Exhalation Technology Ltd genopslog dette
Founder and CEO at Exhalation Technology Ltd, non-invasive Point of Care diagnostic and screening devices for Lung Cancer, Pneumonia and other respiratory conditions (Semifinalist at EIT Health Catapult)
Proud to be selected and awarded as winner of the AstraZeneca prize at the EIT Health Catapult 2024 in Munich today. Congratulation to all the amazing winners. It has been a great experience to be part of this program.
🌟 Announcing the Catapult 2024 Winners! 🌟 We are thrilled to celebrate the outstanding achievements of this year’s Catapult participants. Their resilience and dedication to advancing healthcare have truly set them apart. 🏆 Life Sciences 1st Place: Celex Oncology Innovations Ltd 🏆 Healthtech 1st Place: Acorai 👏 Alex Casta Audience Award: Dymium We thank our amazing sponsors who have also selected their winners and awarded them with prestigious industry prizes. Acorai awarded by Amazon Web Services (AWS) Plio Surgical, MEDICUD and Dymium awarded by eg technology Ltd Digistain® Acorai and Five Lives awarded by Lusíadas Saúde Acorai and Exhalation Technology Ltd by AstraZeneca Are you part of a European start-up seeking intensive training, enhanced credibility, and pan-European visibility? This is your opportunity! 🚀 Applications are now open for the next Catapult edition. Don’t miss your chance to join this transformative journey. [https://lnkd.in/ez7s8W_5